Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Nah, you have to remember, closing up shop and signing a bunch of low quality licensing deals (like the B-UP Alfasigma deal) is our fall back strategy. That's where we were headed with LocustWalk just prior to COVID. It will yield enough money to clear our liabilities and then we shutdown daily operations and become a licensing company.

Brilacidin for Oral Mucositis has a future we just don't know if it's going to be a full partnership or just a 2-6% royalty like B-UP years into the future.

Go IPIX!